SCHEMBL6768273

SCHEMBL6768273

Cc1ccc2nc(C)cc(-c3ccc(C#N)cc3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.53
LMNA P02545 4/20 0.47
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 4/20 0.46
NPSR1 Q6W5P4 3/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
RECQL P46063 1/20 0.46
KMT2A Q03164 1/20 0.46
CYP2A6 P11509 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 4/20 0.41
HSP90AA1 P07900 1/20 0.41
MAPKAPK2 P49137 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HSD11B1 P28845 1/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
NCOA1 Q15788 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28317112 0.86 LMNA (0.58) GRM2LMNAALDH1A1KDM4ENPSR1
SCHEMBL30064613 0.81 ALDH1A1 (0.65) LMNAALDH1A1KDM4ENPSR1MAPT
SCHEMBL14409758 0.81 ALDH1A1 (0.65) LMNAALDH1A1KDM4ENPSR1MAPT
SCHEMBL28883096 0.80 LMNA (0.60) GRM2LMNAALDH1A1KDM4ENPSR1
SCHEMBL6766208 0.74 LMNA (0.56) GRM2LMNAALDH1A1KDM4ENPSR1
SCHEMBL16168947 0.73 GRM2 (0.80) GRM2KMT2A
SCHEMBL28175731 0.73 ALDH1A1 (0.71) GRM2LMNAALDH1A1KDM4ENPSR1
SCHEMBL17206631 0.72 KDM4E (0.43) LMNAALDH1A1KDM4ENPSR1MAPT
SCHEMBL28317085 0.71 CYP1A2 (0.56) ALDH1A1KDM4ENPSR1MAPTMEN1
SCHEMBL14850863 0.71 ALDH1A1 (0.56) GRM2ALDH1A1CYP2A6CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730418-B2 HAVING SUPERIOR STABILITY AND LIGHT EMITTING LUMINANCE CHARACTERISTIC AND HAVING LIGHT EMITTING FUNCTION IN YELLOW RED RANGE KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2004-05-04 US disclosed
US-20030012980-A1 Quinoline derivatives and organic electroluminescent devices KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030012980-A1 Quinoline derivatives and organic electroluminescent devices KCNQ1, KCNQ2, RECQL GRM2 2662/4885LMNA 3072/4885ALDH1A1 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.